Identification of CD4(+) T cell biomarkers for predicting the response of patients with relapsing-remitting multiple sclerosis to natalizumab treatment

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system of autoimmune etiopathogenesis, and is characterized by various neurological symptoms. Glatiramer acetate and interferon-β are administered as first-line treatments for this disease. In non-responsive patients, s...

Descripción completa

Detalles Bibliográficos
Autores principales: Fagone, Paolo, Mazzon, Emanuela, Mammana, Santa, Di Marco, Roberto, Spinasanta, Flaminia, Basile, Maria Sofia, Petralia, Maria Cristina, Bramanti, Placido, Nicoletti, Ferdinando, Mangano, Katia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580020/
https://www.ncbi.nlm.nih.gov/pubmed/31180553
http://dx.doi.org/10.3892/mmr.2019.10283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580020/
https://www.ncbi.nlm.nih.gov/pubmed/31180553
http://dx.doi.org/10.3892/mmr.2019.10283

Ejemplares similares